Efficacy and safety of triple therapy containing berberine hydrochloride, amoxicillin, and rabeprazole in the eradication of <i>Helicobacter pylori</i>-Reference-Cited by-同舟云学术

Efficacy and safety of triple therapy containing berberine hydrochloride, amoxicillin, and rabeprazole in the eradication of Helicobacter pylori

Published:2022-10 Issue:10 Volume:23 Page:568-576
ISSN:1751-2972
Container-title:Journal of Digestive Diseases
language:en
Short-container-title:J of Digest Diseases

Author:

Chen Xing Xing¹²³,Chen Yu Xin¹²,Bi Han Xin¹²,Zhao Xin¹²,Zhang Li Feng²,Liu Jun Ye⁴,Shi Yong Quan¹²^ORCID

Affiliation:

1. Xi'an Medical University Xi'an Shaanxi Province China

2. State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases and Xijing Hospital Air Force Medical University Xi'an Shaanxi Province China

3. The Second Affiliated Hospital of Xi'an Medical College Xi'an Shaanxi Province China

4. Department of Radiation Protective Medicine Air Force Medical University Xi'an Shaanxi Province China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Gastroenterology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1751-2980.13146

Reference45 articles.

1. Prevalence of Helicobacter pylori infection in China: A systematic review and meta‐analysis

2. Consensus on eradication of Helicobacter pylori and prevention and control of gastric cancer in China (2019, Shanghai)

3. An In Vitro Model to Investigate the Role of Helicobacter pylori in Type 2 Diabetes, Obesity, Alzheimer’s Disease and Cardiometabolic Disease

4. Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: A systematic review and meta‐analysis of observational studies

5. Kyoto global consensus report onHelicobacter pylorigastritis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural Products Based on Correa's Cascade for the Treatment of Gastric Cancer Trilogy: Current Status and Future Perspective;Journal of Pharmaceutical Analysis;2024-08

2. Research on drug treatment and the novel signaling pathway of chronic atrophic gastritis;Biomedicine & Pharmacotherapy;2024-07

3. A Mini-review on Helicobacter pylori with Gastric Cancer and Available Treatments;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-03

4. Coptisine inhibits Helicobacter pylori and reduces the expression of CagA to alleviate host inflammation in vitro and in vivo;Journal of Ethnopharmacology;2023-10